Volume 86 Issue 6 | p. 29 | Concentrates
Issue Date: February 11, 2008

Alpharma To Sell Bulk Drug Business

Department: Business

The specialty drugmaker Alpharma has signed a deal to sell its active pharmaceutical ingredients (API) business to investment funds managed by 3i, a private equity firm, for $395 million in cash. The business, with 700 employees at plants in Europe and China, makes several fermentation-based APIs and one synthetic API. Alpharma had sales of $139 million in the first nine months of 2007.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment